DocGo Inc. (NASDAQ:DCGO) Receives Consensus Rating of “Hold” from Analysts

Shares of DocGo Inc. (NASDAQ:DCGO) have been given a consensus rating of “Hold” by the six brokerages that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $2.3750.

A number of research firms have recently commented on DCGO. Cantor Fitzgerald reiterated an “overweight” rating on shares of DocGo in a research report on Monday, May 11th. Wall Street Zen raised DocGo from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a research report on Thursday, June 18th.

DocGo Trading Down 0.4%

Shares of NASDAQ:DCGO opened at $0.62 on Friday. The firm has a 50 day simple moving average of $0.59 and a 200-day simple moving average of $0.65. DocGo has a twelve month low of $0.45 and a twelve month high of $1.78. The company has a market capitalization of $61.72 million, a PE ratio of -0.33 and a beta of 0.99.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings results on Monday, May 11th. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.10). DocGo had a negative return on equity of 44.09% and a negative net margin of 62.23%.The company had revenue of $75.55 million for the quarter, compared to analyst estimates of $72.48 million. As a group, equities research analysts predict that DocGo will post -0.12 EPS for the current fiscal year.

Hedge Funds Weigh In On DocGo

Institutional investors have recently modified their holdings of the business. GSA Capital Partners LLP purchased a new position in shares of DocGo during the second quarter worth about $517,000. Renaissance Technologies LLC raised its stake in DocGo by 167.1% during the 1st quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock valued at $950,000 after acquiring an additional 944,826 shares during the last quarter. Millennium Management LLC lifted its position in DocGo by 878.6% during the 3rd quarter. Millennium Management LLC now owns 766,210 shares of the company’s stock worth $1,042,000 after acquiring an additional 687,911 shares during the period. Goldman Sachs Group Inc. lifted its position in DocGo by 205.4% during the 4th quarter. Goldman Sachs Group Inc. now owns 805,427 shares of the company’s stock worth $707,000 after acquiring an additional 541,670 shares during the period. Finally, Marquette Asset Management LLC purchased a new position in shares of DocGo in the 2nd quarter valued at approximately $175,000. 56.44% of the stock is owned by institutional investors and hedge funds.

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.